These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


193 related items for PubMed ID: 33576392

  • 1. Disappearance of bilateral adrenal tumours: immunodeficiency-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
    Hanai S, Kobayashi K, Kawashima I, Ichijo M, Nakagomi D.
    Rheumatology (Oxford); 2021 Jul 01; 60(7):e255-e257. PubMed ID: 33576392
    [No Abstract] [Full Text] [Related]

  • 2. Methotrexate-associated lymphoproliferative disorder mimicking composite lymphoma.
    Ikeda J, Morii E, Tomita Y, Xu JX, Kimura H, Kohara M, Hoshida Y, Aozasa K.
    Int J Hematol; 2006 May 01; 83(4):363-5. PubMed ID: 16757440
    [No Abstract] [Full Text] [Related]

  • 3. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
    Uchida Y, Hokkoku K, Hatanaka Y, Kikuchi Y, Tashiro H, Sonoo M.
    Rinsho Shinkeigaku; 2018 Aug 31; 58(8):485-491. PubMed ID: 30068810
    [Abstract] [Full Text] [Related]

  • 4. Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.
    Ureshino H, Kadota C, Kurogi K, Miyahara M, Kimura S.
    Intern Med; 2015 Aug 31; 54(17):2235-9. PubMed ID: 26328653
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate-associated lymphoproliferative disorder diagnosed by skin biopsy in a patient with multiple systemic nodules.
    Sakurai K, Murata T, Yamamoto M, Kore-Eda S.
    Eur J Dermatol; 2013 Aug 31; 23(5):723-4. PubMed ID: 24135721
    [No Abstract] [Full Text] [Related]

  • 6. Methotrexate-associated Lymphoproliferative Disease with Multiple Pulmonary Nodules in a Patient with Rheumatoid Arthritis.
    Suemori K, Hasegawa H, Ishizaki J, Matsumoto T, Onishi S, Sada E, Sugita A, Yasukawa M.
    Intern Med; 2015 Aug 31; 54(11):1421-5. PubMed ID: 26028000
    [Abstract] [Full Text] [Related]

  • 7. Cyclosporine and methotrexate for severe rheumatoid arthritis.
    van de Rijn M, Kamel OW.
    N Engl J Med; 1995 Dec 07; 333(23):1568; author reply 1568-9. PubMed ID: 7477181
    [No Abstract] [Full Text] [Related]

  • 8. Iguratimod triggers the relapse of methotrexate-associated lymphoproliferative disorder.
    Nagata H, Kuriyama K, Nishikawa R, Ohshiro M, Yamamoto-Sugitani M, Fujimoto-Hirakawa Y, Matsumoto Y, Iwai T, Tsukamoto T, Mizutani S, Shimura Y, Kobayashi T, Fukuda W, Uchiyama H, Kuroda J.
    Ann Hematol; 2021 Nov 07; 100(11):2849-2850. PubMed ID: 34420071
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report.
    Kamio S, Anazawa U, Watanabe I, Sasaki A, Aoyama R.
    Skeletal Radiol; 2021 Oct 07; 50(10):2117-2123. PubMed ID: 33772624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Rare Case of Methotrexate-Associated Lymphoproliferative Disease in the Orbit.
    Spadaro JZ, Perzia B, Perincheri S, Habib L.
    Ophthalmic Plast Reconstr Surg; 2021 Oct 07; 40(1):e28-e31. PubMed ID: 37791841
    [Abstract] [Full Text] [Related]

  • 15. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
    Tokuhira M, Tamaru JI, Kizaki M.
    J Clin Exp Hematop; 2019 Oct 07; 59(2):72-92. PubMed ID: 31257348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort.
    Shimizu Y, Nakajima A, Inoue E, Shidara K, Sugimoto N, Seto Y, Tanaka E, Momohara S, Taniguchi A, Yamanaka H.
    Clin Rheumatol; 2017 Jun 07; 36(6):1237-1245. PubMed ID: 28455827
    [Abstract] [Full Text] [Related]

  • 19. Pulmonary and retroperitoneal lesions induced by methotrexate-associated lymphoproliferative disorder in a patient with rheumatoid arthritis.
    Yamakawa H, Yoshida M, Katagi H, Hirooka S, Okuda K, Ishikawa T, Takagi M, Kuwano K.
    Mod Rheumatol; 2016 Jun 07; 26(3):441-4. PubMed ID: 24684409
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.
    Horie N, Kawano R, Kaneko T, Shimoyama T.
    Aust Dent J; 2015 Sep 07; 60(3):408-11. PubMed ID: 25302816
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.